1
|
Yu H, Wang Y, Huang J, Yue X, Chu J, Sun G, Gao H, Yang M, Zhang H. Effect of forest cover on lung cancer incidence: a case study in Southwest China. Front Public Health 2024; 12:1466462. [PMID: 39430708 PMCID: PMC11486646 DOI: 10.3389/fpubh.2024.1466462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2024] [Accepted: 09/23/2024] [Indexed: 10/22/2024] Open
Abstract
Introduction Forests are closely linked to human health, particularly about lung cancer incidence. However, there is currently limited research on how forest coverage and different types of forests influence lung cancer rates. This study aims to address this gap by examining how the coverage of various forest types impacts lung cancer incidence in Southwest China, thereby providing theoretical support for health-oriented forest structure planning. Methods We focused on 438 counties in Southwest China, employing spatial autocorrelation analysis (Moran's I) and spatial regression models [including Spatial Lag Model (SLM), Spatial Error Model (SEM), and Spatial Durbin Model (SDM)] to explore the effects of forest coverage and internal forest structure on lung cancer incidence. We used ArcGIS to visualize lung cancer incidence and forest coverage rates across the study area. Results The study found a significant negative correlation between forest coverage and lung cancer incidence. Specifically, for every 1% increase in forest coverage, lung cancer incidence decreased by 0.017 levels. Evergreen forests and mixed forests showed a significant negative impact on lung cancer rates, with evergreen forests having a particularly strong effect; a 1% increase in evergreen forest coverage was associated with a 0.027 level decrease in lung cancer incidence. In contrast, deciduous forests had no significant impact. Additionally, the study revealed a marked spatial heterogeneity in lung cancer incidence and forest coverage across Southwest China: higher lung cancer rates were observed in the eastern regions, while forest coverage was predominantly concentrated in the western and southern regions. Discussion This study demonstrates that increasing forest coverage, particularly of evergreen and mixed forests, can help reduce lung cancer incidence. This effect may be related to the ability of forests to absorb harmful gasses and particulate matter from the air. Furthermore, the spatial heterogeneity in lung cancer incidence suggests that regional economic development levels and urbanization processes may also play significant roles in the spatial distribution of lung cancer rates. The findings provide empirical support for the development of targeted forest conservation and development policies aimed at optimizing regional forest structures to reduce the risk of lung cancer.
Collapse
Affiliation(s)
- Haishi Yu
- Yunnan Normal University Hospital, Yunnan Normal University, Kunming, China
| | - Yang Wang
- Faculty of Geography, Yunnan Normal University, Kunming, China
| | - Jinyu Huang
- Faculty of Geography, Yunnan Normal University, Kunming, China
| | - Xiaoli Yue
- Faculty of Geography, Yunnan Normal University, Kunming, China
| | - Jun Chu
- Department of Geography and Resource Management, The Chinese University of Hong Kong, Hong Kong, China
| | - Guiquan Sun
- Faculty of Geography, Yunnan Normal University, Kunming, China
| | - Han Gao
- Faculty of Geography, Yunnan Normal University, Kunming, China
| | - Min Yang
- Faculty of Geography, Yunnan Normal University, Kunming, China
| | - Hong’ou Zhang
- Guangzhou Institute of Geography, Guangdong Academy of Sciences, Guangzhou, China
| |
Collapse
|
2
|
Yu H, Wang Y, Yue X, Zhang H. Influence of the atmospheric environment on spatial variation of lung cancer incidence in China. PLoS One 2024; 19:e0305345. [PMID: 38889132 PMCID: PMC11185477 DOI: 10.1371/journal.pone.0305345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2024] [Accepted: 05/29/2024] [Indexed: 06/20/2024] Open
Abstract
Conducting this research contributes to a deeper understanding of the correlation between atmospheric environmental quality and lung cancer incidence, and provides the scientific basis for formulating effective environmental protection and lung cancer prevention and control strategies. Lung cancer incidence in China has strong spatial variation. However, few studies have systematically revealed the characteristics of the spatial variation in lung cancer incidence, and have explained the causes of this spatial variation in lung cancer incidence from the perspectives of multiple components of the atmospheric environment to explain this spatial variation in lung cancer incidence. To address research limitations, we first analyze the spatial variation and spatial correlation characteristics of lung cancer incidence in China. Then, we build a spatial regression model using GeoDa software with lung cancer incidence as the dependent variable, five atmospheric environment factors-particulate matter 2.5 (PM2.5) concentration, temperature, atmospheric pressure, and elevation as explanatory variables, and four socio-economic characteristics as control variables to systematically analyze the influence and intensity of these factors on lung cancer incidence. The results show that lung cancer incidence in China has apparent changes in geographical and spatial unevenness, and spatial autocorrelation characteristics. In China, the lung cancer incidence is relatively high in Northeast China, while some areas of high lung cancer incidence still exist in Central China, Southwest China and South China, although the overall lung cancer incidence is relatively low. The atmospheric environment significantly affects lung cancer incidence. Different elements of the atmospheric environment vary in the direction and extent of their influence on the development of lung cancer. A 1% increase in PM2.5 concentration is associated with a level of 0.002975 increase in lung cancer incidence. Atmospheric pressure positively affects lung cancer incidence, and an increase in atmospheric pressure by 1% increases lung cancer incidence by a level of 0.026061. Conversely, a 1% increase in temperature is linked to a level of 0.006443 decreases in lung cancer incidence, and a negative correlation exists between elevation and lung cancer incidence, where an increase in elevation by 1% correlates with a decrease in lung cancer incidence by a level of 0.000934. The core influencing factors of lung cancer incidence in the seven geographical divisions of China exhibit variations. This study facilitates our understanding of the spatial variation characteristics of lung cancer incidence in China on a finer scale, while also offering a more diverse perspective on the impact of the atmospheric environment on lung cancer incidence.
Collapse
Affiliation(s)
- Haishi Yu
- Yunnan Normal University Hospital, Kunming, Yunnan, China
| | - Yang Wang
- Faculty of Geography, Yunnan Normal University, Kunming, Yunnan, China
| | - Xiaoli Yue
- Faculty of Geography, Yunnan Normal University, Kunming, Yunnan, China
| | - Hong’ou Zhang
- Guangzhou Institute of Geography, Guangdong Academy of Sciences, Guangzhou, Guangdong, China
| |
Collapse
|
3
|
Wang W, Wang Y, Qi X, He L. Spatial pattern and environmental drivers of breast cancer incidence in Chinese women. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2023; 30:82506-82516. [PMID: 37326721 DOI: 10.1007/s11356-023-28206-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Accepted: 06/07/2023] [Indexed: 06/17/2023]
Abstract
Breast cancer (BC) had the highest incidence of all cancers in Chinese women. However, studies on spatial pattern and environmental drivers of BC were still lacked as they were either limited in a small area or few considered the comprehensive impact of multiple risk factors. In this study, we firstly performed spatial visualization and the spatial autocorrelation analysis based on Chinese women breast cancer incidence (BCI) data of 2012-2016. Then, we explored the environmental drivers related to BC by applying univariate correlation analysis and geographical detector model. We found that the BC high-high clusters were mainly distributed in the eastern and central regions, such as Liaoning, Hebei, Shandong, Henan, and Anhui Provinces. The BCI in Shenzhen was significantly higher than other prefectures. Urbanization rate (UR), per capita GDP (PGDP), average years of school attainment (AYSA), and average annual wind speed (WIND) had higher explanatory power on spatial variability of the BCI. PM10, NO2, and PGDP had significant nonlinear enhanced effect on other factors. Besides, normalized difference vegetation index (NDVI) was negatively associated with BCI. Therefore, high socioeconomic status, serious air pollution, high wind speed, and low vegetation cover were the risk factors for BC. Our study may able to provide evidence for BC etiology research and precise identification of areas requiring focused screening.
Collapse
Affiliation(s)
- Wenhui Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China
| | - Yu Wang
- Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China
| | - Xin Qi
- Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
| | - Li He
- Department of Sociology, School of Humanities and Social Science, Xi'an Jiaotong University, Xi'an, 710049, Shaanxi, China
| |
Collapse
|
4
|
Zhang Y, Niu J, Zhang S, Si X, Bian TT, Wu H, Li D, Sun Y, Jia J, Xin E, Yan X, Li Y. Comparative study on the gastrointestinal- and immune- regulation functions of Hedysari Radix Paeparata Cum Melle and Astragali Radix Praeparata cum Melle in rats with spleen-qi deficiency, based on fuzzy matter-element analysis. PHARMACEUTICAL BIOLOGY 2022; 60:1237-1254. [PMID: 35763552 PMCID: PMC9246251 DOI: 10.1080/13880209.2022.2086990] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Revised: 05/31/2022] [Accepted: 06/02/2022] [Indexed: 05/27/2023]
Abstract
CONTEXT Hedysari Radix Praeparata Cum Melle (HRPCM) and Astragali Radix Praeparata Cum Melle (ARPCM) are used interchangeably in clinics to treat spleen-qi deficiency (SQD) symptom mainly including gastrointestinal dysfunction and decreased immunity, which has unknown differences in efficacy. OBJECTIVE To investigate the differences between HRPCM and ARPCM on intervening gastrointestinal- and immune-function with SQD syndrome. MATERIALS AND METHODS After the SQD model was established, the Sprague-Dawley (SD) rats were randomly divided into nine groups (n = 10): normal; model; Bu-Zhong-Yi-Qi Pills; 18.9, 12.6 and 6.3 g/kg dose groups of HRPCM and ARPCM. Gastrointestinal function including d-xylose, gastrin, amylase vasoactive intestinal peptide, motilin, pepsin, H+/K+-ATPase, Na+/K+-ATPase, sodium-glucose cotransporter 1 (SGLT1), glucose transporter 2 (GLUT2) and immune function including spleen and thymus index, blood routine, interleukin (IL)-2, IL-6, interferon-γ (IFN-γ), tumour necrosis factor-α (TNF-α), immunoglobulin (Ig) M, IgA, IgG and delayed-type hypersensitivity (DTH) were detected. Finally, the efficacy differences were analysed comprehensively by the fuzzy matter-element method. RESULTS In regulating immune, the doses differences in efficacy between HRPCM and ARPCM showed in the high-dose (18.9 g/kg), but there were no differences in the middle- and low- dose (12.6 and 6.37 g/kg); the efficacy differences were primarily reflected in levels of IL-6, IFN-γ, TNF-α and IgM in serum, and the mRNA expression of IL-6 and IFN-γ in the spleen. In regulating gastrointestinal, the efficacy differences were primarily reflected in the levels of D-xylose, MTL, and GAS in serum, and the mRNA and protein expression of SGLT1 and GLUT2 in jejunum and ileum. DISCUSSION AND CONCLUSIONS HRPCM is more effective than ARPCM on regulating gastrointestinal function and immune function with SQD syndrome. Therefore, we propose that HRPCM should be mainly used to treat SQD syndrome in the future.
Collapse
Affiliation(s)
- Yugui Zhang
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Jiangtao Niu
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Shujuan Zhang
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Xinlei Si
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Tian-Tian Bian
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Hongwei Wu
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Donghui Li
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Yujing Sun
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Jing Jia
- College of Acupuncture-Moxibustion and Tuina, Laboratory of Molecular Biology, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Erdan Xin
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Xingke Yan
- College of Acupuncture-Moxibustion and Tuina, Laboratory of Molecular Biology, Gansu University of Chinese Medicine, Lanzhou, PR China
| | - Yuefeng Li
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou, PR China
- Key Laboratory of Standard and Quality of Chinese Medicine Research of Gansu, Engineering Research Center of Chinese Medicine Pharmaceutical Process of Gansu, Gansu University of Chinese Medicine, Lanzhou, PR China
- Scientific Research and Experimental Center, Gansu University of Chinese Medicine, Lanzhou, PR China
| |
Collapse
|
5
|
Liu Q, Huang Q, Yu Z, Wu H. Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions. THE CLINICAL RESPIRATORY JOURNAL 2022; 16:216-225. [PMID: 35081265 PMCID: PMC9060101 DOI: 10.1111/crj.13472] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/26/2021] [Revised: 11/02/2021] [Accepted: 12/25/2021] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To study the relationship between clinical characteristics and anaplastic lymphoma kinase (ALK) fusions, c-ros oncogene 1, receptor tyrosine kinase (ROS1) gene fusions, and epidermic growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) patients to distinguish these different types. METHODS Both ALK, ROS1 gene rearrangements and EGFR mutations testing were performed. The clinical characteristics and associated pulmonary abnormalities were investigated. RESULTS Four hundred fifty-three NSCLC patients were included for analysis. One hundred seventy (37.5%), 32 (7.1%), and 9 cases (2.0%) with EGFR mutations, ALK gene fusions, and ROS1 gene fusions were identified, respectively. The EGFR-positive and ALK&ROS1-positive were more common in female (χ2 = 61.934, P < 0.001 and χ2 = 28.152, P < 0.001), non-smoking (χ2 = 59.315, P < 0.001 and χ2 = 11.080, P = 0.001), and adenocarcinoma (χ2 = 44.864, P < 0.001 and χ2 = 12.318, P = 0.002) patients; proportion of patients with emphysema was lower (χ2 = 35.494, P < 0.001 and χ2 = 15.770, P < 0.001) than the wild-type patients. The results of logistic regression analysis indicated that female (adjusted odds ratio [OR] 1.834, 95% confidence interval [CI] 1.069-3.144, P = 0.028), non-smoking (adjusted OR 2.504, 95% CI 1.456-4.306, P = 0.001), lung adenocarcinoma (adjusted OR 4.512, 95% CI 2.465-8.260, P < 0.001), stage III-IV (adjusted OR 2.232, 95% CI 1.066-4.676, P = 0.033), and no symptoms of emphysema (adjusted OR 2.139, 95% CI 1.221-3.747, P = 0.008) were independent variables associated with EGFR mutations. Young (adjusted OR 3.947, 95% CI 1.873-8.314, P < 0.001) and lung adenocarcinoma (adjusted OR 2.950, 95% CI 0.998-8.719, P = 0.050) were associated with ALK/ROS1 fusions. CONCLUSIONS EGFR mutations were more likely to occur in non-smoking, stage III-IV, and female patients with lung adenocarcinoma, whereas ALK&ROS1 gene fusions were more likely to occur in young patients with lung adenocarcinoma. Emphysema was less common in patients with EGFR mutations.
Collapse
Affiliation(s)
- Qinghua Liu
- Center for Pathological Diagnostics, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
- Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
| | - Qingyan Huang
- Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
- Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
| | - Zhikang Yu
- Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
- Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
| | - Heming Wu
- Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
- Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital)Meizhou Academy of Medical SciencesMeizhouP. R. China
| |
Collapse
|
6
|
Fan W, Xu L, Zheng H. Using Multisource Data to Assess PM 2.5 Exposure and Spatial Analysis of Lung Cancer in Guangzhou, China. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19052629. [PMID: 35270346 PMCID: PMC8910196 DOI: 10.3390/ijerph19052629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Accepted: 02/21/2022] [Indexed: 02/01/2023]
Abstract
Elevated air pollution, along with rapid urbanization, have imposed higher health risks and a higher disease burden on urban residents. To accurately assess the increasing exposure risk and the spatial association between PM2.5 and lung cancer incidence, this study integrated PM2.5 data from the National Air Quality Monitoring Platform and location-based service (LBS) data to introduce an improved PM2.5 exposure model for high-precision spatial assessment of Guangzhou, China. In this context, the spatial autocorrelation method was used to evaluate the spatial correlation between lung cancer incidence and PM2.5. The results showed that people in densely populated areas suffered from higher exposure risk, and the spatial distribution of population exposure risk was highly consistent with the dynamic distribution of the population. In addition, areas with PM2.5 roughly overlapped with areas with high lung cancer incidence, and the lung cancer incidence in different locations was not randomly distributed, confirming that lung cancer incidence was significantly associated with PM2.5 exposure. Therefore, dynamic population distribution has a great impact on the accurate assessment of environmental exposure and health burden, and it is necessary to use LBS data to improve the exposure assessment model. More mitigation controls are needed in highly populated and highly polluted areas.
Collapse
Affiliation(s)
| | - Linyu Xu
- Correspondence: ; Tel.: +86-10-5880-0618
| | | |
Collapse
|
7
|
Zhang N, Wang Y, Yu H, Zhang Y, Xiang F, Jiang H, Zheng Y, Xiong Y, Wang Z, Chen Y, Jiang Q, Shao Y, Zhou Y. Distance to highway and factory density related to lung cancer death and associated spatial heterogeneity in effects in Jiading District, Shanghai. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2021; 28:64536-64551. [PMID: 34312750 DOI: 10.1007/s11356-021-15438-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Accepted: 07/09/2021] [Indexed: 06/13/2023]
Abstract
This study aimed to determine the spatial effects of traffic- and industrial-related pollution on the mortality for lung cancer (LC). We conducted a retrospective cohort study by using the data from LC registry in Jiading District for the period from 2002 to 2012. Standard parametric model with Weibull distribution was used for spatial survival analysis. Shorter distance to highway (adjusted odds ratio (aOR) = 1.15, 95% confidence interval (CI): 1.03-1.30) and higher factory density (aOR = 1.20, 95% CI: 1.05-1.37) were significantly associated with an increased risk of LC death, and there was a spatial difference in the associations between northern and southern areas of Jiading District. The risk was high in suburbs as compared with urban areas. Traffic- and industrial-related pollution were significantly associated with an increased risk of LC death, which showed a spatial variation. Further studies are needed to better understand the current LC status in the suburbs and to reduce health disparities.
Collapse
Affiliation(s)
- Na Zhang
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
| | - Yingjian Wang
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
| | - Hongjie Yu
- The Jiading District Center for Disease Control and Prevention, Shanghai, 201800, China
| | - Yiying Zhang
- The Jiading District Center for Disease Control and Prevention, Shanghai, 201800, China
| | - Fang Xiang
- The Jiading District Center for Disease Control and Prevention, Shanghai, 201800, China
| | - Honglin Jiang
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
| | - Yingyan Zheng
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
| | - Ying Xiong
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
| | - Zhengzhong Wang
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
| | - Yue Chen
- School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada
| | - Qingwu Jiang
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China
| | - Yueqin Shao
- The Jiading District Center for Disease Control and Prevention, Shanghai, 201800, China.
| | - Yibiao Zhou
- Fudan University School of Public Health, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China.
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China.
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'An Road, Xuhui District, Shanghai, 200032, China.
| |
Collapse
|